Handok to sell Amaryl-M firstly to overseas market in March.

Published: 2007-03-16 06:59:00

Updated: 2007-03-16 06:59:00

Handok plans to supply Amaryl-M, an anti-hyperglycemic drug developed by Handok Central Research Institute, to the overseas markets from coming March this year, mainly to Peru for Amaryl-M 1/250mg (glymepyride 1mg plus metformin 250mg) and Amaryl 2/500mg (glymeyride 2mg plus metformin 500mg) as m...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK